thyssenkrupp nucera KGaANCH2
NCH2 logo
Fair Value
€10.74
Share price03 May
€7.7328.0% undervalued intrinsic discount
Loading
1Y-22.66%
7D11.95%

Global Decarbonization Policies Will Fuel Green Hydrogen Momentum

Analyst Consensus Target compiles analysts opinions to create narratives on stocks using the Analysts Consensus Price Target, forecasted revenue and earnings figures, as well as the transcripts of earnings calls.

Published
27 Jan 25
Updated
03 May 26
Views
112
Not Invested

Last Update 03 May 26

Fair value Decreased 1.38%

NCH2: Long Dated Hydrogen Orders Will Support Future Margin Upside

Analysts have trimmed their price target for thyssenkrupp nucera KGaA slightly, from €10.89 to €10.74, reflecting updated assumptions for slower revenue growth, a higher discount rate and a lower future P/E multiple, partly offset by a stronger profit margin outlook.

What's in the News

  • The company hosted an Analyst/Investor Day, providing the market with a detailed update on the business and project pipeline (Analyst/Investor Day).
  • The company was commissioned by Spanish energy company Moeve to supply 300 MW of electrolyzers for a hydrogen plant in Andalusia, Spain, under an Engineering, Procurement, Fabrication and Supply contract, with order volume in the low three digit million euro range and most revenue recognition planned for fiscal year 2026/27 (Client Announcement).
  • The company was commissioned by Juno Joule Green Energy in India to conduct a FEED study for a 260 MW water electrolysis plant aimed at producing green hydrogen and green ammonia for export to Europe, with a potential EPF contract dependent on a final investment decision, which could be taken in fiscal year 2026/27 (Client Announcement).
  • The company reduced earnings guidance for fiscal year 2025/26, with Group sales now expected in a range of €450 million to €550 million and Group EBIT forecast as a loss of €80 million to a loss of €30 million (Corporate Guidance, Lowered).
  • The company had earlier reiterated guidance for fiscal year 2025/26 with expected order intake of €350 million to €900 million, Group sales of €500 million to €600 million and consolidated EBIT between a loss of €30 million and breakeven (Corporate Guidance, Reiterated).

Valuation Changes

  • Fair Value: trimmed slightly from €10.89 to €10.74 per share.
  • Discount Rate: increased modestly from 6.48% to 6.53%, reflecting a higher required return in the model.
  • Revenue Growth: forecast adjusted from roughly a 1.06% decline to a 3.87% decline, implying a more cautious view on future € revenue trends.
  • Profit Margin: projected margin raised from 5.43% to 6.38%, indicating expectations for stronger profitability on future € sales.
  • Future P/E: target multiple reduced from 43.17x to 39.55x, pointing to a slightly lower valuation applied to future earnings.
3 viewsusers have viewed this narrative update

Key Takeaways

  • Positioned to benefit from rising global green hydrogen demand, with policy support and growing engineering contracts pointing to strengthened long-term growth and order visibility.
  • Service expansion, strategic acquisitions, and advanced R&D support higher-margin revenues, improved earnings quality, and greater competitiveness in core and emerging markets.
  • Revenue and earnings are at risk due to project delays, weak order intake, high reliance on a few large contracts, and ongoing innovation pressures.

Catalysts

About thyssenkrupp nucera KGaA
    Engages in the development, engineering, procurement, commissioning, and licensing of high-performance electrolysis technologies in Germany, Italy, the Middle East, Africa, South America, Asia, and internationally.
What are the underlying business or industry changes driving this perspective?
  • Recent project delays and smaller average project size have weighed on near-term revenues, but thyssenkrupp nucera sits at the center of a major long-term shift as global decarbonization policies and corporate net-zero mandates support the structural ramp-up in green hydrogen demand, likely driving a reacceleration in order intake and revenue growth as regulatory certainty and infrastructure buildout progresses.
  • The increasing volume of paid FEED (Front-End Engineering Design) and engineering contracts-especially in Europe, which remains the most active region for green hydrogen-signals forthcoming conversion into firm, large-scale orders within 6-12 months, offering improved medium-term revenue visibility.
  • Expansion of the service and aftermarket business in the chlor-alkali segment (with rising orders from the Middle East, Central Europe, U.S., and China) is boosting recurring, higher-margin revenues-evidenced by the stable or growing EBIT in this segment-supporting gross margin expansion and enhanced earnings quality over time.
  • Strategic technology acquisitions (such as Green Hydrogen Systems) and accelerated R&D, including SOEC pilot plant launches, are enabling thyssenkrupp nucera to lower the levelized cost of hydrogen, strengthen its technological edge, and address a broader spectrum of industrial decarbonization use cases, improving the company's long-term competitiveness and margin potential.
  • U.S. policy support for green hydrogen, driven by recent clarity on funding eligibility and tax incentives, is creating renewed momentum in a key growth market; strong positioning on advanced projects there and in the Middle East means the company is poised to benefit from increased order activity and improved revenue trajectory once permitting and FID hurdles resolve.
thyssenkrupp nucera KGaA Earnings and Revenue Growth

thyssenkrupp nucera KGaA Future Earnings and Revenue Growth

Assumptions

How have these above catalysts been quantified?

  • Analysts are assuming thyssenkrupp nucera KGaA's revenue will decrease by 3.9% annually over the next 3 years.
  • Analysts assume that profit margins will increase from -1.0% today to 6.4% in 3 years time.
  • Analysts expect earnings to reach €41.4 million (and earnings per share of €0.24) by about May 2029, up from -€7.4 million today.
  • In order for the above numbers to justify the price target of the analysts, the company would need to trade at a PE ratio of 39.5x on those 2029 earnings, up from -148.9x today. This future PE is greater than the current PE for the DE Construction industry at 33.0x.
  • Analysts expect the number of shares outstanding to remain consistent over the next 3 years.
  • To value all of this in today's terms, we will use a discount rate of 6.53%, as per the Simply Wall St company report.

Risks

What could happen that would invalidate this narrative?
  • Delays and cancellations in large-scale green hydrogen projects, especially due to offtake risks, lack of infrastructure, and regulatory uncertainty, have led to a downsized and less valuable project pipeline, which could result in lower revenue growth and reduced order intake over the coming years.
  • Order intake in the green hydrogen segment has been soft, with project postponements and client reluctance to make final investment decisions, raising the risk of a slowdown in sales and order backlog impacting future top-line growth.
  • Workload in green hydrogen is currently declining, and the company expects a phase of sales slowdown next year due to lagging order intake this year-potentially leading to lower revenue and underutilization of fixed costs, which may pressure net margins and earnings.
  • Persistent competitive and technological pressures require continued investment in R&D and new product development (such as scaling up SOEC and pressurized AWE), but high capital intensity and the need for recurring innovation could weigh on operating efficiency and long-term margins if operating leverage is not achieved.
  • The company's near
  • and mid-term sales outlook is heavily reliant on successfully converting paid engineering contracts and final investment decisions (FIDs) on a handful of large projects, introducing significant concentration risk that could translate into material revenue and earnings volatility if these projects face further delays or cancellations.

Valuation

How have all the factors above been brought together to estimate a fair value?

  • The analysts have a consensus price target of €10.74 for thyssenkrupp nucera KGaA based on their expectations of its future earnings growth, profit margins and other risk factors.
  • However, there is a degree of disagreement amongst analysts, with the most bullish reporting a price target of €15.0, and the most bearish reporting a price target of just €8.0.
  • In order for you to agree with the analysts, you'd need to believe that by 2029, revenues will be €648.6 million, earnings will come to €41.4 million, and it would be trading on a PE ratio of 39.5x, assuming you use a discount rate of 6.5%.
  • Given the current share price of €8.72, the analyst price target of €10.74 is 18.8% higher.
  • We always encourage you to reach your own conclusions though. So sense check these analyst numbers against your own assumptions and expectations based on your understanding of the business and what you believe is probable.

Have other thoughts on thyssenkrupp nucera KGaA?

Create your own narrative on this stock, and estimate its Fair Value using our Valuator tool.

Create Narrative

How well do narratives help inform your perspective?

Disclaimer

AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.

Read more narratives

Fair Value vs Share Price

€10.74
vs €7.7328.0% undervalued intrinsic discount
PastFuture0969m202020222024202620282029Revenue €648.6mEarnings €41.4m
-3.9%
Revenue growth
6.4%
Profit margin

Recent News & Updates

No updates

Recent updates

No updates

Stay ahead on thyssenkrupp nucera KGaA

  • Fair value estimate changes
  • Narrative and analyst updates
  • Key company announcements

Company analysis

Flawless balance sheet with reasonable growth potential.

Market cap€976.4m
PB1.4x
Estimated Growth12.2%
Dividend YieldN/A
Full analysis

CEO & management

Werner Ponikwar
CEO
1.3yrs
CEO Tenure

Engages in the development, engineering, procurement, commissioning, and licensing of electrolysis technologies in Germany, Saudi Arabia, Sweden, the United States, and internationally.